A Prospective Research Investigation of Ischemia Using MCG

A Prospective Research Investigation of Ischemia Using SandboxAQ Magnetocardiography Device

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Inclusion Criteria:

• Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
• Ability for participant to comply with study requirements
• Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
• Written informed consent

Exclusion Criteria:

• Present STEMI
• Pregnant or breastfeeding
• Having an active atrial fibrillation episode as seen on most current 12-lead ECG
• Active thoracic metal implant
• Poor access to follow-up